Medco Health Reaches New 52-Week High (MHS)

NEW YORK ( TheStreet) -- Medco Health Solutions (NYSE: MHS) hit a new 52-week high Monday as it is currently trading at $67, above its previous 52-week high of $66.38 with 1.3 million shares traded as of 9:35 a.m. ET. Average volume has been 3.3 million shares over the past 30 days.

Medco Health has a market cap of $24 billion and is part of the services sector and wholesale industry. Shares are up 14.7% year to date as of the close of trading on Friday.

Medco Health Solutions, Inc., a healthcare company, provides clinically-driven pharmacy services for private and public employers, health plans, labor unions, government agencies, and individuals primarily in the United States. The company has a P/E ratio of 17.7, below the average wholesale industry P/E ratio of 18.1 and equal to the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Medco Health as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, growth in earnings per share, solid stock price performance and increase in net income. We feel these strengths outweigh the fact that the company has had generally poor debt management on most measures that we evaluated. You can view the full Medco Health Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Economist Perspective: Brexit Endgame in Sight?

Economist Perspective: Brexit Endgame in Sight?

Flashback Friday: Johnson & Johnson Hits Take Historic Plunge

Flashback Friday: Johnson & Johnson Hits Take Historic Plunge

Dow, S&P, Nasdaq Are All in Correction Territory Following Stock Selloff

Dow, S&P, Nasdaq Are All in Correction Territory Following Stock Selloff

Procter & Gamble Helps Lead Dow Jones After Upgrade From Morgan Stanley

Procter & Gamble Helps Lead Dow Jones After Upgrade From Morgan Stanley

5 Highly Anticipated Tech IPOs to Watch in 2019

5 Highly Anticipated Tech IPOs to Watch in 2019